3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
2
Recurrence
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lymphoma
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Hematologic Neoplasms
1
Carcinosarcoma
1
Carcinoma, Endometrioid
1
Breast Neoplasms
1
Advanced Solid Malignancy,
1
Interventions
tusamitamab ravtansine
2
Ramucirumab
2
Gemcitabine
2
Docetaxel
2
pembrolizumab
1
necitumumab
1
Paclitaxel
1
LY3023414
1
Erlotinib Hydrochloride
1
Cisplatin
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Non-small Cell Lung Cancer Metastatic
×
capivasertib
×
Clear all
No trials found.